Novartis | NOVN - Ebit

سعر السهم
115.64
التغيير اليومي
2.10 1.85%
شهريا
-3.47%
سنويا
25.94%
Q2 التوقعات
113.62




Ebit تغيير تاريخ
AbbVie USD 4.73B 1.08B 2026-03
Alcon AG USD 317M 17M 2025-12
Almirall EUR 30.23M 12.8M 2025-12
Amgen USD 3.83B 130M 2026-03
AstraZeneca USD 7.11B 4.14B 2026-03
Autolus Therapeutics Ltd USD -72.47M 845K 2025-12
Bayer EUR 1.11B 1.51B 2025-12
Biogen USD 514.3M 502.8M 2026-03
Bristol-Myers Squibb USD 3.56B 90M 2026-03
Eli Lilly USD 9.78B 792M 2026-03
Fresenius EUR 713M 139M 2025-12
Fresenius Medical Care EUR 663M 213.06M 2025-12
Galapagos EUR 780.56M 822.23M 2025-12
Genmab DKK 260M 199M 2025-12
Gilead Sciences USD 2.96B 551M 2025-12
GlaxoSmithKline GBP 2.29B 856M 2026-03
GRIFOLS EUR 352.11M 20.18M 2025-09
Hikma Pharmaceutical USD 348M 31M 2025-12
J&J USD 6.62B 1.51B 2026-03
Lonza CHF 673M 54M 2025-06
Merck EUR 474M 738M 2025-12
Merck USD -1.88B 8.12B 2026-03
Novartis USD 4.18B 118M 2026-03
Novartis USD 4.06B 413M 2025-12
Novo Nordisk DKK 32.38B 1.7B 2025-12
Orion EUR 114.8M 213.3M 2026-03
Pfizer USD 4.65B 71M 2025-12
Philips EUR 719M 390M 2025-12
Recordati EUR 278.23M 112.58M 2025-12
Regeneron Pharmaceuticals USD 744.8M 153.8M 2026-03
Roche Holding CHF 9.56B 2.1B 2025-12
Sanofi EUR 1.94B 239M 2026-03
UCB EUR 1.29B 571M 2025-12